Lymphoma Dr. Raid Jastania Dec 2006. By the end of this session you should be able to: –Discuss the basis of the classification of lymphomas –Know the.

Slides:



Advertisements
Similar presentations
Lymphoma Classification
Advertisements

Non-Hodgkin’s Lymphoma
Edoardo Pescarmona Dipartimento di Medicina Sperimentale
Rick Allen.  Leukaemia involves widespread bone marrow involvement and a presence in peripheral blood.  Lymphoma’s arise in discrete tissue masses (commonly.
MANTLE CELL Lymphoma (WITH EMPHASIS ON THE gi TRACT)
Proposed WHO Classification of Lymphoid neoplasm
TODAY B CELL DEVELOPMENT.
Lymphoid System Dr. Raid Jastania Dec, By the end of this session you should be able to: –Describe the components of the lymphoid system –List the.
Non-Hodgkin’s Lymphoma
By the end of this session you should know:
Lymphoproliferative disorders
Lymphomas Clonal disorders of lymphoid cells at various stages of differentiation HODGKIN L. NON-HODGKIN L.  immature cells (precursors)  mature cells.
Lymphoma Nada Mohamed Ahmed , MD, MT (ASCP)i.
LYMPHOMA.
Timothy S. Fenske, MD April 5th, 2014
Lymphoma DR: Gehan Mohamed.
Lymphoma David Lee MD, FRCPC. Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of.
Lymphoma. ALLMMCLLLymphomas Hematopoietic stem cell Neutrophils Eosinophils Basophils Monocytes Platelets Red cells Myeloid progenitor Myeloproliferative.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Leukopenia, leukocytosis
Chapter 11 B-Cell Generation, Activation, and Differentiation.
L YMPHOMA FOR THE G ENERALIST Lee Berkowitz, MD. G OALS AND O BJECTIVES 1. Understand the importance of pathology and staging in the approach to management.
Lymphoma D S O’Briain February Lymphadenopathy Enlarged lymph nodes Benign: soft, mobile, tender, Malign: hard, fixed, 1. Reactive hyperplasia (lymphadenitis),
T-cell/histiocyte-rich large B cell lymphoma Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital.
© Cancer Research UK 2005 Registered charity number Table One: Numbers and rates of new cases, non-Hodgkin lymphoma, UK, 2006 EnglandWalesScotlandN.IrelandUK.
Chapter 4: B Cell Development Objectives 1.Discover how lymphoid stem cells become B cells destined to make antibodies 2.Understand the importance of Ig.
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
B Cell Development Kathleen E. Sullivan MD PhD Children’s Hospital of Philadelphia.
Lymphoid System and Immune cells Immunology Unit Dept. of Pathology.
Non-Hodgkins Lymphoma. risk factor Elderly Men Predisposed: primary and secondary immunodeficiency states – HIV infection – Undergone organ transplantation.
Highlights of Immune System. Topic Outline Overview of the Immune System 1 st and 2 nd lines of Defense The Immune System  B cells  The antibody & antibody.
Lymphoproliferative disorders. Several clinical conditions in which lymphocytes are produced in excessive quantities ( Lymphocytosis) Lymphoma Malignant.
Hematology and Hematologic Malignancies
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
Chapter 13 Lymphocyte Maturation and Antigen Receptor Expression
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Non Hodgkin”s Lymphoma -- Histology appearance -- Cell of orgin -- Immunophenotype -- Molecular biology -- Clinical featres -- Prognosis -- Out-come of.
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Acute Leukemia Kristine Krafts, M.D..
B CELL DEVELOPMENT AND ACTIVATION In healthy people, there are mature B cells with the capacity to make antibodies to virtually any antigen. Bone marrow.
11. B Cell Recognition and Response to Antigens 王 家 鑫王 家 鑫.
.. Т-cellВ-cell Lymphoproliferative disorders – lymphatic hemoblastosis, in which the substratum of the tumor are malignisated lymphocytes and/or their.
Humoral immunity Antibody structure Antibody diversity
R4 고원진 / 백선경 교수님 JOURNAL OF CLINICAL ONCOLOGY Volume 29, Number 14, May 2011 The Gray Zone Between Burkitt’s Lymphoma And Diffuse Large B-Cell Lymphoma.
Chapter 12 The diseases of Hematopoietic and Lymphoid System Liu weiping Department of Pathology West China School of Medicine Sichuan University.
Chronic leukemias أ. م. د. محمد شنين علي العبادي معاون عميد كلية الطب / جامعة كربلاء ورئيس فرع الامراض والطب العدلي M. B. Ch. B. & F. I. C. P.(Hematopathology)
GASTROINTESTINAL MALT LYMPHOMA Scott R. Owens, M.D.
by Elaine S. Jaffe, Nancy Lee Harris, Harald Stein, and Peter G
LYMPHOMAS H.A MWAKYOMA, MD.
Lymphoma David Lee MD, FRCPC.
Acute Leukemia Kristine Krafts, M.D..
B Cells Ali Roghanian, University of Southampton Medical School, UK
T and B Cell Development
Acute myeloid leukemia
Development of B lymphocytes
Lymphoproliferative disorders
B Cell Development in Bone Marrow and Peripheral Lymphoid Tissue Part II March 23, :00-11:00.
Antibody production and B cell differentiation
CHU Ulg Liège, Centre for Human Genetics
Cancer Stem Cells in Hematopoietic Malignancies
با نام و یاد خدا.
Aggiornamento in Ematologia Clinica
Cells of the immune system
Lymphoma Ali Al Khader, M.D. Faculty of Medicine
Jianzhong Chen, Ph. D. Institute of Immunology, ZJU
Immunogenetics chapter 22 select topics pp
Marc C. Levesque, MD, PhD, E. William St. Clair, MD 
LYMPHOPROLIFERATIVE DISORDERS
Introduction & haematological malignancies
Presentation transcript:

Lymphoma Dr. Raid Jastania Dec 2006

By the end of this session you should be able to: –Discuss the basis of the classification of lymphomas –Know the different stages of B lymphocyte –List common genetic abnormalities in lymphomas –Classify Hodgkin lymphoma and the difference between the subtypes

Lymphoma Classification WHO –Lymphoid, Myeloid, Histiocytic Definitions: –Precursor, mature, stage of differentiation, naïve, peripheral, small cell, large cell –CD’s Common types: Follicular lymphoma, Diffuse large B cell lymphoma Age: –Non Hodgkin: 6 th - 7 th decade –Hodgkin: 3 rd decade

Risk factors: –Abnormalities in the immune system. –EBV –HHV8 –Hepatitis C virus –H. pylori

The Journey of the B cells Bone marrowPeripheral blood Lymph node

The Journey of the B cells Bone marrow- Blast- VDJ gene rearrangement- mature naïve Ig positive cells- IgM, IgD, CD5+ Antigen- transformation- proliferation- mature B cell IgM Germinal center maturation, Somatic mutation. IgG, IgA plasma cells and memory cells. Plasma cells- bone marrow

The Journey of the B cells Bone marrow- Blast- VDJ gene rearrangement- mature naïve Ig positive cells- IgM, IgD –CD20, CD19,CD10, TdT, CD5+/- Antigen- transformation- proliferation- mature B cell IgM –CD20, CD10, Bcl-2 Germinal center maturation, Somatic mutation. –CD20 IgG, IgA plasma cells and memory cells. –Loose all the B cell markers CD138+ Plasma cells- bone marrow

The Journey of the B cells Bone marrowPeripheral blood Lymph node

Genetics Follicular lymphoma t(14;18) –Bcl-2 over expression Mantle cell lymphoma: t(11;14) –CyclinD1 over expression Burkitt lymphoma: t(8;14) –C-myc over expression

Classification Based on: –Morphology –Immunophenotyping –Clinical presentation –Molecular/cytogenetic findings

Classification Predominantly disseminated: lymphoma/Leukemia Primary extranodal Primary nodal

Classification Predominantly disseminated: lymphoma/Leukemia –CLL, lymphoplasmacytic lymphoma, Myeloma Primary extranodal –Marginal zone lymphoma Primary nodal –Follicular lymphoma, mantle cell lymphoma Aggressive types –Diffuse large B cell lymphoma, Burkitt lymphoma